Yılmaz, SedaÖner, Pinar2022-09-222022-09-222022Yılmaz S, Öner P. Low α-N-acetylgalactosaminidase plasma concentration correlates with the presence and severity of the bipolar affective disorder. World J Biol Psychiatry. 2022 Sep 14:1-11. doi: 10.1080/15622975.2022.2124451. Epub ahead of print. PMID: 36102137.1562-2975http://doi.org/10.1080/15622975.2022.2124451https://hdl.handle.net/20.500.12713/3177Objectives: Believing that a neurodevelopmental pathology may cause bipolar affective disorder (BAD), we aimed to measure the concentrations of ?-N-acetylgalactosaminidase (?-NAGAL), a lysosomal enzyme. Methods: The study included 32 patients with BAD and 32 healthy controls. The Young Mania Rating Scale was used to measure the severity of the disease. Serum ?-N-acetylgalactosaminidase concentrations were measured in all blood samples using the human ?-N-acetylgalactosaminidase ELISA Kit. Results: A statistically significant difference was found in the ?-NAGAL values between the groups. The mean ?-NAGAL values of BAD patients are lower than the mean ?-NAGAL values of the control group. A strong negative and statistically significant relationship was found between the ?-NAGAL values of patients with BAD and their Young Mania Rating Scale scores. And a positive strong correlation was found between the age of onset of the disease and ?-NAGAL levels. Conclusions: Low ?-N-acetylgalactosaminidase concentrations may cause accumulation of some glycoproteins in the lysosomes in the brain during the gestational period, producing the clinical symptoms of BAD. ?-N-acetylgalactosaminidase deficiency may not be the only cause of BAD, but it may be an important factor in the etiology of this disease.eninfo:eu-repo/semantics/closedAccessBipolar Affective DisorderNeurodevelopmentα-N-AcetylgalactosaminidaseArticle11136102137WOS:0008605382000012-s2.0-85139122573Q310.1080/15622975.2022.2124451Q1